AdvanSource Biomaterials is an ISO certified materials technology company, specializing in medical grade materials for long and short term applications. The Company's materials are USP Class VI and are available in both standard as well as custom formulations - offering tailored mechanical characteristics in order to enhance and optimize device design and functionality. AdvanSource Biomaterials develops innovative biomaterials which may be used as structural engineering polymers, co-extrusion layers or as specialized coatings for a wide variety of material substrates.
Type
Public
HQ
Wilmington, US
Founded
1998
Size (employees)
15 (est)-21%
AdvanSource Biomaterials was founded in 1998 and is headquartered in Wilmington, US
Report incorrect company information

AdvanSource Biomaterials Office Locations

AdvanSource Biomaterials has an office in Wilmington
Wilmington, US (HQ)
235 Andover St
Show all (1)
Report incorrect company information

AdvanSource Biomaterials Financials and Metrics

AdvanSource Biomaterials Financials

AdvanSource Biomaterials's revenue was reported to be $2.28 m in FY, 2017
USD

Revenue (Q2, 2018)

702 k

Gross profit (Q2, 2018)

486 k

Gross profit margin (Q2, 2018), %

69.2%

Net income (Q2, 2018)

(335 k)

EBIT (Q2, 2018)

(239 k)

Market capitalization (31-Oct-2017)

1.8 m

Closing share price (31-Oct-2017)

0.1

Cash (30-Sep-2017)

288 k

EV

1.6 m
AdvanSource Biomaterials's current market capitalization is $1.8 m.
Annual
USDFY, 2017

Revenue

2.3 m

Cost of goods sold

853 k

Gross profit

1.4 m

Gross profit Margin, %

63%
Quarterly
USDQ3, 2014Q1, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q3, 2017Q2, 2018

Revenue

685 k621 k1.2 m1 m592 k800 k467 k702 k

Cost of goods sold

168 k228 k322 k305 k242 k259 k174 k216 k

Gross profit

517 k393 k849 k736 k350 k541 k293 k486 k

Gross profit Margin, %

75%63%73%71%59%68%63%69%
Annual
USDFY, 2017

Cash

27 k

Inventories

189 k

Current Assets

454 k

PP&E

1.9 m
Quarterly
USDQ3, 2014Q1, 2015Q2, 2018

Cash

108 k133 k288 k

Inventories

378 k150 k289 k

Current Assets

745 k471 k998 k

PP&E

2.2 m2.1 m1.9 m
Annual
USDFY, 2017

Net Income

(509 k)

Depreciation and Amortization

57 k

Accounts Payable

174 k

Interest Paid

349 k
Quarterly
USDQ3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q3, 2017

Net Income

41 k(132 k)337 k181 k(111 k)37 k(172 k)

Depreciation and Amortization

43 k

Accounts Payable

(84 k)247 k298 k327 k217 k186 k305 k336 k

Interest Paid

70 k
USDY, 2017

EV/EBIT

-6.7 x

Revenue/Employee

41.3 k

Debt/Equity

-0.2 x

Financial Leverage

-4.1 x
Show all financial metrics
Report incorrect company information